Oncology & Cancer

Histone deacetylase 6 inhibition enhances oncolytic viral therapy

Gliomas are extremely aggressive brain tumors that are resistant to standard cancer therapeutics. Oncolytic viral (OV) therapy, which uses engineered viruses to infect and target tumor cells for destruction by the immune ...

Oncology & Cancer

ASCO: Risks of whole brain radiotx may outweigh benefits

(HealthDay)—Targeted radiation in the treatment of brain metastases leads to less cognitive damage than radiation for the entire brain, while survival is similar, researchers reported Sunday at the annual meeting of the ...

Diseases, Conditions, Syndromes

Investigating acute hepatitis of unknown origin in children

Since Fall 2021, an increasing number of unexplained cases of severe acute hepatitis have been reported in children. Epidemiologic investigation is ongoing, and, to date, a cause of these outbreaks has not been identified. ...

Diseases, Conditions, Syndromes

Routine screening for genital herpes infection not recommended

The U.S. Preventive Services Task Force (USPSTF) recommends against routine serologic screening (via a blood test) for genital herpes simplex virus infection in asymptomatic adolescents and adults, including those who are ...

Diseases, Conditions, Syndromes

HSV-1 prevalence 47.8 percent in 14- to 49-year-olds

(HealthDay)—The prevalence of herpes simplex virus type 1 (HSV-1) and HSV-2 is 47.8 and 11.9 percent, respectively, for individuals aged 14 to 49 years, according to a February data brief published by the U.S. Centers for ...

page 11 from 16